Causation of Crohn's disease by Mycobacterium avium subspecies paratuberculosis

Canadian Journal of Gastroenterology

Volumn 14, Issue 6, 2000, Pages 521-539

  Hermon Taylor, John ^a   Bull, Timothy John ^a   Sheridan, Joseph Michael ^a   Cheng, Jun ^a   Stellakis, Michael Laurence ^a   Sumar, Nasira ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Antimicrobial chemotherapy; Crohn's disease; Food safety; Johne's disease; Mycobacterium avium subspecies paratuberculosis; Polymerase chain reaction; Potable water; Vaccine

Indexed keywords

CLARITHROMYCIN; MACROLIDE; MYCOBACTERIUM VACCINE; RIFABUTIN; TUBERCULOSTATIC AGENT;

BACTERIUM CULTURE; CROHN DISEASE; DISEASE TRANSMISSION; FOOD SAFETY; HUMAN; IMMUNE RESPONSE; MILK; MYCOBACTERIOSIS; MYCOBACTERIUM PARATUBERCULOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; WATER SUPPLY;

EID: 0033920121     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2000/798305     Document Type: Review

References (369)

1. Johne HA, Frothingham L. Ein eigenthümlicher Fall von Tuberculose beim Rind. Deutsche Zeitschr Tierm Path 1895;21:438-54.
2. Dalziel TK. Chronic interstitial enteritis. BMJ 1913;ii:1068-70.
3. Thorel M-F, Krichevsky M, Levy-Frebault VV. Numerical taxonomy of mycobactin-dependent mycobacteria, emended description of Mycobacterium avium, and description of Mycobacterium avium subsp. avium subsp. nov., Mycobacterium avium subsp. paratuberculosis subsp. nov., and Mycobacterium avium subsp silvaticum subsp. nov. Int J Syst Bacteriol 1990;40:254-60.
4. Frothingham R, Wilson KH. Molecular phylogeny of the Mycobacterium avium complex demonstrates clinically meaningful divisions. J Infect Dis 1994;169:305-12.
5. Böddinghaus B, Wolters J, Heikens W, Böttger EC. Phylogenetic analysis and identification of different serovars of Mycobacterium intracellulare at the molecular level. FEMS Microbiol Lett 1990;70:197-203.
6. Van Der Giessen JWB, Eger A, Haagsma J, Haring RM, Gaastra W, Van Der Zeijst BAM. Amplification of 16S rRNA sequences to detect Mycobacterium paratuberculosis. J Med Microbiol 1992;36:255-63.
7. Hurley SS, Splitter GA, Welch RA. Deoxyribonucleic acid relatedness of Mycobacterium paratuberculosis to other members of the family Mycobocterioceae. Int J Syst Bacteriol 1988;38:143-6.
8. Frothingham R. Evolutionary bottlenecks in the agents of tuberculosis, leprosy, and paratuberculosis. Med Hypoth 1999;52:95-9.
9. Portaels F, Larsson L, Smeets P. Isolation of mycobacteria from healthy persons' stool. Int J Leprosy 1988;56:468-71.
10. Kallinowski F, Wassmer A, Hofmann MA, et al. Prevalence of enteropathogenic bacteria in surgically treated chronic inflammatory bowel disease. Hepatogastroenterology 1998;45:1552-8.
11. Green EP, Tizard MLV, Moss MT, et al. Sequence and characteristics of IS900, an insertion element identified in a human Crohn's disease isolate of Mycobacterium paratuberculosis. Nucleic Acids Res 1989;17:9063-73.
12. Tizard MLV, Bull T, Millar D, et al. A low G+C content genetic island in Mycobacterium avium subsp. paratuberculosis and M. avium subsp. silvaticum with homologous genes in Mycobacterium tuberculosis. Microbiology 1998;144:3413-23.
13. Ellingson JL, Bolin CA, Stabel JR. Identification of a gene unique to Mycobacterium avium subspecies paratuberculosis and application to diagnosis of paratuberculosis. Mol Cell Probes 1998;12:133-42.
14. Doran TJ, Davies JK, Radford AJ, Hodgson ALM. Putative functional domain within ORF2 on the Mycobacterium insertion sequences IS900 and IS902. Immunol Cell Biol 1994;72:427-34.
15. Bruton CJ, Chater KF. Nucleotide sequence of IS110, an insertion sequence of Streptomyces coelicolor A3(2). Nucleic Acids Res 1987;15:7053-65.
16. Leskiw BK, Mevarech M, Barritt LS, et al. Discovery of an insertion sequence, IS116, from Streptomyces clavuligerus and its relatedness to other transposable elements from actinomycetes. J Gen Microbiol 1990;136:1251-8.
17. Kunze ZM, Wall S, Appelberg R, Silva MT, Portaels F, McFadden JJ. IS901, a new member of a widespread class of atypical insertion sequences, is associated with pathogenicity in Mycobacterium avium. Mol Microbiol 1991;5:2265-72.
18. Moss MT, Malik ZP, Tizard MLV, Green EP, Sanderson JD, Hermon-Taylor J. IS902, an insertion element of the chronic- enteritis-causing Mycobacterium avium subsp. silvaticum. J Gen Microbiol 1992;138:139-45.
19. Collins P, Matthews PRJ, McDiarmid A, Brown A. The pathogenicity of Mycobacterium avium and related mycobacteria for experimental animals. J Med Microbiol 1983;16:27-35.
20. Hernandez Perez A, Fomukong NG, Hellyer T, Brown IN, Dale JW. Characterization of IS1110, a highly mobile genetic element from Mycobacterium avium. Mol Microbiol 1994;12:717-24.
21. Bull TJ, Pavlik I, Carcia MJ, Svastova P, Sumar N, Hermon-Taylor J. Strains of Mycobacterium avium subsp avium containing a new insertion sequence IS1613 related to IS900 have an altered phenotype. Presented at the European Society for Mycobacteriology, Lucerne, July 4 to 7, 1999.
22. Roiz MP, Palenque E, Guerrero C, Garcia MJ. Use of restriction fragment length polymorphism as a genetic marker for typing Mycobacterium avium strains. J Clin Microbiol 1995;33:1380-91.
23. Doran T, Tizard MLV, Millar D, et al. IS900 targets translation initiation signals in Mycobacterium avium subsp. paratuberculosis to facilitate expression of its hed gene. Microbiology 1997;143:547-52.
24. Bull T, Hermon-Taylor J, Pavlik I, El Zaatari F, Tizard MLV. Characterization of IS900 loci in Mycobacterium avium subsp paratuberculosis and development of multiplex PCR screening. Microbiology. (In press)
25. Tizard MLV, Moss MT, Sanderson JD, Austen BM, Hermon-Taylor J. p43, the protein product of the atypical insertion sequence IS900, is expressed in Mycobacterium paratuberculosis. J Gen Microbiol 1992;138:1729-36.
26. Mishina D, Katsel P, Brown ST, Gilberts ECAM, Greenstein RJ. On the etiology of Crohn disease. Proc Natl Acad Sci USA. 1996;93:9816-20.
27. Hacker J, Blum-Oehler G, Mühldorfer I, Tschäpe H. Pathogenicity islands of virulent bacteria: structure, function and impact on microbial evolution. Mol Microbiol 1997;23:1089-97.
28. Cole ST, Brosch R, Parkhill J, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998;393:537-44.
29. Slauch JM, Lee AA, Mahan MJ, Mekalanos JJ. Molecular characterization of the oafA locus responsible for acetylation of Salmonella typhimurium O-antigen: oafA is a member of a family of integral membrane trans-acylases. J Bacteriol 1996;178:5904-9.
30. Clark CA, Beltrame J, Manning PA. The oac gene encoding a lipopolysaccharide O-antigen acetylase maps adjacent to the integrase-encoding gene on the genome of Shigella flexneri bacteriophage Sf6. Gene 1991;107:43-52.
31. Stroeher UH, Karageorgos LE, Morona R, Manning PA. Serotype conversion in Vibrio cholerae O1. Proc Natl Acad Sci USA 1992;89:2566-70.
32. Colwell RR. Global climate and infectious disease: The cholera paradigm. Science 1996;274:2025-31.
33. Gordon SV, Brosch R, Billault A, Gamier T, Eiglmeier K, Cole ST. Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays. Mol Microbiol 1999;32:643-55.
34. Behr MA, Wilson MA, Gill WP, et al. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 1999;284:1520-3.
35. Belisle JT, Pascopella L, Inamine JM, Brennan PJ, Jacobs WR Jr. Isolation and expression of a gene cluster responsible for biosynthesis of the glycopeptidolipid antigens of Mycobacterium avium. J Bacteriol 1991;173:6991-7.
36. Mills JA, McNeil MR, Belisle JT, Jacobs WR Jr, Brennan PJ. Loci of Mycobacterium avium ser2 gene cluster and their functions. J Bacteriol 1994;176:4803-8.
37. Eckstein TM, Silbaq FS, Chatterjee D, Kelly NJ, Brennan PJ, Belisle JT. Identification and recombinant expression of a Mycobacterium avium rhamnosyltransferase gene (rtfA) involved in glycopeptidolipid biosynthesis. J Bacteriol 1998;180:5567-73.
38. Camphausen RT, Jones RL, Brennan PJ. Structure and relevance of the oligosaccharide hapten of Mycobacterium avium serotype 2. J Bacteriol 1986;168:660-7.
39. Belisle JT, Klaczkiewicz K, Brennan PJ, Jacobs WR Jr, Inamine JM. Rough morphological variants of Mycobacterium avium. Characterization of genomic deletions resulting in the loss of glycopeptidolipid expression. J Biol Chem 1993;268:10517-23.
40. Pace NR. A molecular view of microbial diversity and the biosphere. Science 1997;276:734-40.
41. Hugenholtz P, Goebel BM, Pace NR. Impact of culture-independent studies on the emerging phylogenetic view of bacterial diversity. J Bacteriol 1998;180:4765-74.
42. Twort FW, Ingram GLY. A method for isolating and cultivating the Mycobacterium enteritidis chronicae pseudotuberculosae bovis, Johne, and some experiments on the preparation of a diagnostic vaccine for pseudo-tuberculosis enteritis of bovines. Proc R Soc Lond 1912;84:517-45.
43. Merkal RS, Kopecky KE, Larsen AB, Thurston JR. Improvements in the techniques for primary cultivation of Mycobacterium paratuberculosis. Am J Vet Res 1964;25:1290-4.
44. Whittington RJ, Marsh I, Turner MJ, et al. Rapid detection of Mycobacterium paratuberculosis in clinical samples from ruminants and in spiked environmental samples by modified BACTEC 12B radiometric culture and direct confirmation by IS900 PCR. J Clin Microbiol 1989;36:701-7.
45. Whittington RJ, Marsh I, McAllister S, Turner MJ, Marshall DJ, Fraser CA. Evaluation of modified BACTEC 12B radiometric medium and solid media for culture of Mycobacterium avium subsp. paratuberculosis from sheep. J Clin Microbiol 1999;37:1077-83.
46. LeClerc JE, Li B, Payne WL, Cebula TA. High mutation frequencies among Escherichia coli and Salmonella pathogens. Science 1996;274:1208-12.
47. Sniegowski PD, Gerrish PJ, Lenski RE. Evolution of high mutation rates in experimental populations of E. coli. Science 1997;387:703-5.
48. Rainey PB, Travisano M. Adaptive radiation in a heterogeneous environment. Nature 1998;394:69-72.
49. Gupta S, Ferguson N, Anderson R. Chaos, persistence, and evolution of strain structure in antigenically diverse infectious agents. Science 1998;280:912-5.
50. Taddei F, Matic I, Godelle B, Radman M. To be a mutator, or how pathogenic and commensal bacteria can evolve rapidly. Trends Microbiol 1997;5:427-9.
51. Hausner M, Wuertz S. High rates of conjugation in bacterial biofilms as determined by quantitative in situ analysis. Appl Environ Microbiol 1999;65:3710-3.
52. Sokurenko EV, Hasty DL, Dykhuizen DE. Pathoadaptive mutations: gene loss and variation in bacterial pathogens. Trends Microbiol 1999;7:191-5.
53. Mooi FR, Bik EM. The evolution of epidemic Vibrio cholerae strains. Trends Microbiol 1997;5:161-5.
54. Morelli G, Malomy B, Muller K, et al. Clonal descent and microevolution of Neisseria meningitidis during 30 years of epidemic spread. Mol Microbiol 1997;25:1047-64.
55. Collins DN, Gabric DM, de Lisle GW. Identification of two groups of Mycobacterium paratuberculosis strains by restriction endonuclease analysis and DNA hybridization. J Clin Microbiol 1990;28:1591-6.
56. Whipple D, Kapke P, Vary C. Identification of restriction fragment length polymorphisms in DNA from Mycobacterium paratuberculosis. J Clin Microbiol 1990;28:2561-4.
57. Bauerfeind R, Benazzi S, Weiss R, Schleisser T, Willems H, Baljer G. Molecular characterisation of Mycobacterium paratuberculosis isolates from sheep, goats, and cattle by hybridization with a DNA probe to insertion element IS900. J Clin Microbiol 1996;34:1617-21.
58. Collins DM, Cavaignac S, de Lisle GW. Use of four DNA insertion sequences to characterize strains of the Mycobacterium avium complex isolated from animals. Mol Cell Probes 1997;11:373-80.
59. Feizabadi MM, Robertson ID, Hope A, Cousins DV, Hampson DJ. Differentiation of Australian isolates of Mycobacterium paratuberculosis using pulsed-field gel electrophoresis. Aust Vet J 1997;75:887-9.
60. Francois B, Krishnamoorthy R, Elion J. Comparative study of Mycobacterium paratuberculosis strains isolated from Crohn's disease and Johne's disease using restriction fragment length polymorphism and arbitrarily primed polymerase chain reaction. Epidemiol Infect 1997;118:227-33.
61. Pavlik I, Horvathova A, Dvorska L, et al. Standardisation of restriction fragment length polymorphism analysis for Mycobacterium avium subspecies paratuberculosis. J Microbiol Methods 1999;38:155-67.
62. Scheibl P, Gerlach G-F. Differentiation of Mycobacterium paratuberculosis isolates by rDNA-spacer analysis and random amplified polymorphic DNA patterns. Vet Microbiol 1997;51:151-8.
63. March I, Whittington R, Cousins D. PCR-restriction endonuclease analysis for identification and strain typing of Mycobacterium avium subsp. paratuberculosis and Mycobacterium avium subsp. avium based on polymorphisms in IS1311. Mol Cell Probes 1999;13:115-26.
64. Kremer K, van Soolingen D, Frothingham R, et al. Comparison of methods based on different molecular epidemiological markers for typing of Mycobacterium tuberculosis complex strains: interlaboratory study of discriminatory power and reproducibility. J Clin Microbiol 1999;37:2607-18.
65. Twort FW, Ingram GLY. A Monograph on Johne's Disease. London: Bailliere, Tindall & Cox, 1913.
66. Doyle TM. Johne's disease. Vet Rec 1956;68:869-86.
67. Chiodini JH, Van Kruiningen HJ, Merkal RS. Ruminant paratuberculosis (Johne's disease): the current status and future prospects. Cornell Vet 1984;74:218-62.
68. Cocito C, Gilot P, Coene M, de Kesel M, Poupart P, Vannuffel P. Paratuberculosis. Clin Microbiol Rev 1994;7:328-45.
69. Stehman SM. Paratuberculosis in small ruminants, deer, and South American camelids. Vet Clin North Am Food Anim Pract 1996;12:441-55.
70. Riemann HP, Abbas B. Diagnosis and control of bovine paratuberculosis (Johne's disease). Adv Vet Sci Comp Med 1983;27:481-506.
71. Ringdal G. Johne's disease in pigs. Nord Vet Med 1963;15:217-38.
72. Larsen AB, Harley MS, Moon W, Merkal RS. Susceptibility of swine to Mycobacterium paratuberculosis. Am J Vet Res 1971;32:589-95.
73. McClure HM, Chiodini RJ, Anderson DC, Swenson RB, Thayer WR, Coutu JA. Mycobacterium paratuberculosis infection in a colony of stumptail macaques (Macaca arctoides). J Infect Dis 1987;155:1011-9.
74. Larsen AB, Moon HW. Experimental Mycobacterium paratuberculosis infection in chickens. Am J Vet Res 1972;33:1231-5.
75. Larsen AB, Moon HW, Merkal RS. Susceptibility of horses to Mycobacterium paratuberculosis. Am J Vet Res 1972;33:2185-9.
76. Larsen AB, Miller JM, Kermal RS. Subcutaneous exposure of calves to Mycobacterium paratuberculosis compared with intravenous and oral exposures. Am J Vet Res 1977;38:1669-71.
77. Nakamatsu M, Fujimoto Y, Satoh H. The pathological study of paratuberculosis in goats, centered around the formation of remote lesions. Jpn J Vet Res 1968;16:103-19.
78. Whitlock RH, Rosenberger AE, Sweeney RW, Spencer PA. Distribution of M. paratuberculosis in tissues of cattle from herds infected with Johne's disease. In: Chiodini RJ, Hines ME, Collins MT, eds. Proceedings of the Fifth International Colloquium on Paratuberculosis. Rehoboth: International Association for Paratuberculosis Inc, 1996:168-74.
79. Gwozdz JM, Reichel MP, Murray A, Mankteloww, West DM, Thompson KG. Detection of Mycobacterium avium subsp paratuberculosis in bovine tissues and blood by the polymerase chain reaction. Vet Microbiol 1997;51:233-44.
80. Larsen AB, Kopecky KE. Mycobacterium paratuberculosis in reproductive organs and semen of bulls. J Am Vet Med Assoc Res 1970;32:255-8.
81. Larsen AB, Stalheim OHV, Hughes DE, Appell LH, Richards WD, Himes EM. Mycobacterium paratuberculosis in the semen and genital organs of a semen-donor bull. J Am Vet Med Assoc 1981;179:169-71.
82. Kopecky KE, Larsen AB, Merkal RS. Uterine infection in ovine paratuberculosis. Am J Vet Res 1967;28:1043-5.
83. Koenig GJ, Hoffsis GF, Shulaw WP, Bech-Nielsen S, Rings DM, St-Jean G. Isolation of Mycobacterium paratuberculosis from mononuclear cells in tissues, blood and mammary glands of cows with advanced paratuberculosis. Am J Vet Res 1993;54:1441-5.
84. McQueen DS, Russell EG. Culture of Mycobacterium paratuberculosis from bovine foetuses. Aust Vet J 1979;55:203-4.
85. Sweeney RW, Whitlock RH, Rosenberger AE. Mycobacterium paratuberculosis isolated from fetuses of infected cows not manifesting signs of the disease. Am J Vet Res 1992;53:477-80.
86. Carrigan MJ, Seaman JT. The pathology of Johne's disease in sheep. Aust Vet J 1990;67:47-50.
87. Clarke CJ, Little D. The pathology of ovine paratuberculosis: gross and histological changes in the intestine and other tissues. J Comp Pathol 1996;114:419-37.
88. Perez V, Garcia Marin JF, Badiola JJ. Description and classification of different types of lesion associated with natural paratuberculosis infection in sheep. J Comp Pathol 1996;114:107-22.
89. Perez V, Tellechea J, Badiola JJ, Gutierrez M, Garcia Marin JF. Relation between serologic response and pathologic findings in sheep with naturally acquired paratuberculosis. Am J Vet Res 1997;58:799-803.
90. Buergelt CD, Hall C, McEntee K, Duncan JR. Pathological evaluation of paratuberculosis in naturally infected cattle. Vet Pathol 1978;15:196-207.
91. Whitlock RH, Buergelt C. Preclinical and clinical manifestations of paratuberculosis (including pathology). Vet Clin North Am Food Anim Pract 1996;12:345-6.
92. Clarke CJ. The pathology and pathogenesis of paratuberculosis in ruminants and other species. J Comp Pathol 1997;116:217-61.
93. Emsbo P. Terminal or regional ileitis in swine. Nord Vet Med 1951;3:1-28.
94. Van Kruiningen HJ. Canine colitis comparable to regional enteritis and mucosal colitis of man. Gastroenterology 1972;62:1128-42.
95. Benazzi S, El Hamidi M, Schliesser T. Paratuberculosis in sheep flocks in Morocco: a serological, microscopical and cultural survey. J Vet Med 1996;43:213-9.
96. Boelaert F, Walravens K, Biront P, Vermeersch JP, Berkvens D, Godfroid J. Prevalence of paratuberculosis (Johne's disease) in the Belgian cattle population. In: Manning EJB, Collins MT, eds. Proceedings of the Sixth International Colloquium on Paratuberculosis. Rehoboth: International Association for Paratuberculosis Inc, 1999:76-88.
97. Kalis CHJ, Barkema HW, Hesselink JW. Certification of dairy herds as free of paratuberculosis using culture of strategically pooled fecal samples. In: Manning EJB, Collins MT, eds. Proceedings of the Sixth International Colloquium on Paratuberculosis. Rehoboth: International Association for Paratuberculosis Inc, 1999:55-8.
98. Mainar-Jaime RC, Vazquez-Boland JA. Factors associated with seroprevalence to Mycobacterium paratuberculosis in small-ruminant farms in the Madrid region (Spain). Prev Vet Med 1998;34:317-27.
99. Power SB. Johne's disease - an emerging disease in Ireland. Irish Vet J 1994;47:220-3.
100. Cetinkaya B, Egan K, Harbour DA, Morgan KL. An abattoir-based study of the prevalence of subclinical Johne's disease in adult cattle in south west England. Epidemiol Infect 1996;116:373-9.
101. Chiodini RJ, Van Kruiningen HJ. The prevalence of paratuberculosis in culled New England cattle. Cornell Vet 1986;76:91-104.
102. Merkal RS, Whipple DL, Sacks JM, Snyder GR. Prevalence of Mycobacterium paratuberculosis in ileocecal lymph nodes of cattle culled in the United States. J Am Vet Med Assoc 1987;190:676-80.
103. NcNab WB, Meek AH, Duncan JR, Martin SW, Van Dreumel AA. An epidemiological study of paratuberculosis in dairy cattle in Ontario: study design and prevalence estimates. Can J Vet Res 1991;55:246-51.
104. Collins MT, Sockett DC, Goodger WJ, Conrad TA, Thomas CB, Carr DJ. Herd prevalence and geographic distribution of, and risk factors for, bovine paratuberculosis in Wisconsin. J Am Vet Med Assoc 1994;204:636-41.
105. Stabel JR. Johne's Disease: A hidden threat. J Dairy Sci 1998;81:283-8.
106. Wells SJ, Ott SL, Garber LP, Bulaga LL. Johne's disease on U.S. dairy operations: results from the NAHMS Dairy 96 Study. In: Chiodini RJ, Hines ME, Collins MT, eds. Proceedings of the Fifth International Colloquium on Paratuberculosis. Rehoboth: International Association for Paratuberculosis Inc, 1996:140-2.
107. Johnson-Ifearulundu Y, Kaneene JB. Distribution and environmental risk factors for paratuberculosis in dairy cattle herds in Michigan. Am J Vet Res 1999;60:589-96.
108. Doyle TM. Isolation of Johne's bacilli from the udders of clinically affected cows. Br Vet J 1954;110:218.
109. Smith HW. The examination of milk for the presence of Mycobacterium Johnei. J Pathol Bacteriol 1960;80:440-2.
110. Taylor TK, Wilks CR, McQueen DS. Isolation of Mycobacterium paratuberculosis from the milk of a cow with Johne's disease. Vet Record 1981;109:532-3.
111. Sweeney RW, Whitlock RH, Rosenberger AE. Mycobacterium paratuberculosis cultured from milk and supramammary lymph nodes of infected asymptomatic cows. J Clin Microbiol 1992;30:166-71.
112. Streeter RN, Hoffsis GF, Bech-Nielsen S, Shulaw WP, Rings DM. Isolation of Mycobacterium paratuberculosis from colostrum and milk of subclinically infected cows. Am J Res 1995;56:1322-4.
113. Chapman JS, Bernard JS, Speight M. Isolation of mycobacteria from raw milk. Am Rev Respir Dis 1965;91:351-5.
114. Chapman JS, Speight M. Isolation of atypical mycobacteria from pasteurized milk. Am Rev Respir Dis 1968;98:52-4.
115. Fleming DW, Cochi SL, MacDonald KL, et al. Pasteurized milk as a vehicle of infection in an outbreak of Listeriosis. N Engl J Med 1985;312:404-7.
116. Sharp JCM. Infections associated with milk and dairy products in Europe and North America, 1980-85. Bull World Health Org 1987;65:397-406.
117. Collins MT. Mycobacterium paratuberculosis: A potential food-borne pathogen? J Dairy Sci 1997;80:3445-8.
118. Mason O, Rowe MT, Ball HJ. Is Mycobacterium paratuberculosis a possible agent in Crohn's disease? Implications for the dairy industry. Milchwissenschaft 1997;52:311-6.
119. Chiodini RJ, Hermon-Taylor J. The thermal resistance of Mycobacterium paratuberculosis in raw milk under conditions simulating pasteurization. J Vet Diagn Invest 1993;5:629-31.
120. Grant IR, Ball HJ, Neill SD, Rowe MT. Inactivation of Mycobacterium paratuberculosis in cows' milk at pasteurization temperatures. Appl Environ Microbiol 1996;62:631-6.
121. Meylan M, Rings DM, Shulaw WP, Kowalski JJ, Bech-Nielsen S, Hoffsis GF. Survival of Mycobacterium paratuberculosis and preservation of immunoglobulin G in bovine colostrum under experimental conditions simulating pasteurization. Am J Vet Res 1996;57:1580-5.
122. Hope AF, Tulk PA, Condron RJ. Pasteurization of Mycobacterium paratuberculosis in whole milk. In: Chiodini RJ, Hives ME, Colins MT, eds. Proceedings of the Fifth International Colloquium on Paratuberculosis. Rehoboth: International Association for Paratuberculosis Inc, 1996:377-82.
123. Grant IR, Ball HJ, Rowe MT. Thermal inactivation of several Mycobacterium spp. in milk by pasteurization. Lett Appl Microbiol 1996;22:253-6.
124. Sung N, Collins MT. Thermal tolerance of Mycobacterium paratuberculosis. Appl Environ Microbiol 1998;64:999-1005.
125. Grant IR, Ball HJ, Rowe MT. Effect of high-temperature, short-time (HTST) pasteurization on milk containing low numbers of Mycobacterium paratuberculosis. Lett Appl Microbiol 1998;26:166-70.
126. Grant IR. Does Mycobacterium paratuberculosis survive current pasteurization conditions? Appl Environ Microbiol 1998;64:2760.
127. Stabel JR, Steadham EM, Bolin CA. Heat inactivation of Mycobacterium paratuberculosis in raw milk: Are current pasteurization conditions effective? Appl Environ Microbiol 1997;63:4975-7.
128. Keswani J, Frank JF. Thermal inactivation of Mycobacterium paratuberculosis in milk. J Food Protect 1998;61:974-8.
129. Millar D, Ford J, Sanderson J, et al. IS900 PCR to detect Mycobacterium paratuberculosis in retail supplies of whole pasteurized cows' milk in England and Wales. Appl Environ Microbiol 1996;62:3446-52.
130. Grant IR, Ball HJ, Rowe MT. Effect of higher pasteurization temperatures, and longer holding times at 72°C, on the inactivation of Mycobacterium paratuberculosis in milk. Lett Appl Microbiol 1999;28:461-5.
131. Grant IR, Ball HJ, Rowe MT. Isolation of Mycobacterium paratuberculosis from milk by immunomagnetic separation. Appl Environ Microbiol 1998;64:3153-8.
132. Pagan R, Condon S, Sala F. Effects of several factors on the heat-shock-induced thermotolerance of Listeria monocytogenes. Appl Environ Microbiol 1997;63:3225-32.
133. Rowan NJ, Anderson JG. Effects of above-optimum growth temperatute and cell morphology on thermotolerance of Listeria monocytogenes cells suspended in bovine milk. Appl Environ Microbiol 1998;64:2065-71.
134. Sorqvist S. Heat resistance of Listeria monocytogenes by two recovery media used with and without cold preincubation. J Appl Bacteriol 1993;74:428-32.
135. Dodd CER, Sharman RL, Bloomfield SF, Booth IR, Stewart GSAB. Inimical processes: Bacterial self-destruction and sub-lethal injury. Trends Food Sci Technol 1997;8:238-41.
136. Tholozan JL, Cappelier JM, Tissier JP, Delattre G, Federighi M. Physiological characterization of viable-but-nonculturable Campylobacter jejuni cells. Appl Environ Microbiol 1999;65:1110-6.
137. Colwell RR, Brayton P, Herrington D, Tall B, Huq A, Levine MM. Viable but non-culturable Vibrio cholerae 01 revert to a cultivable state in the human intestine. World J Microbiol Biotechnol 1996;12:28-31.
138. Rahn K, Shin S, Wilson J, et al. Milk as a potential source of human exposure to Mycobacterium paratuberculosis. American Society for Microbiology 98th General Meeting, Atlanta, May 17 to 22, 1998:504. (Abst U53)
139. Stewart GSAB. Challenging food microbiology from a molecular perspective. Microbiology 1997;143:2099-108.
140. Hammer P, Knappstein K, Hahn G. Significance of Mycobacterium paratuberculosis in milk. Bull Int Dairy Fed 1998;330:12-6.
141. Dairy Facts and Figures. London: National Dairy Council, 1998:163.
142. Sweeney RW, Whitlock RH, Hamir AN, Rosenberger AE, Herr SA. Isolation of Mycobacterium paratuberculosis after oral inoculation in uninfected cattle. Am J Vet Res 1992;53:1312-4.
143. Lugton IW. Mucosa-associated lymphoid tissues as sites for uptake, carriage and excretion of tubercle bacilli and other pathogenic mycobactetia. Immunol Cell Biol 1999;77:364-72.
144. Miles CA, Mackey BM. A mathematical analysis of microbial inactivation at linearly rising temperatures: calculation of the temperature rise needed to kill Listeria monocytogenes in different foods and methods for dynamic measurements of D and z values. J Appl Bacteriol 1994;77:14-20.
145. Francis J. Bovine Tuberculosis. London: Staples Press Ltd, 1947.
146. Humphriss E, Peden D, Wright HD. The adequacy of commercial pasteurisation for destruction of tubercle bacilli. Lancet 1937;ii:151-2.
147. Jorgensen JB. Survival of Mycobacterium paratuberculosis in slurry. Nord Vet Med 1977;6:267-70.
148. Stehman SM, Rossiter CA, Shin SJ, Chang YF, Lein DH. Johne's disease in a fallow deer herd: Accuracy of fecal culture and results of environmental sampling. In: Chiodini RJ, Hines ME, Collins MT, eds. Proceedings of the Fifth International Colloquium on Paratuberculosis. Rehoboth: International Association for Paratuberculosis Inc, 1996:183-9.
149. Greig A, Stevenson K, Henderson D, et al. Epidemiological study of paratuberculosis in wild rabbits in Scotland. J Clin Microbiol 1999;37:1746-51.
150. Pell AN. Manure and microbes: Public and animal health problem? J Dairy Sci 1997;80:2673-81.
151. Kudva IT, Blanch K, Hovde CJ. Analysis of Escherichia coli 0157:H7 survival in ovine or bovine manure and manure slurry. Appl Environ Microbiol 1998;64:3166-74.
152. Anderson BC. Cryptosporidiosis in bovine and human health. J Dairy Sci 1998;81:3036-41.
153. Ford TE. Microbiological safety of drinking water: United States and global perspectives. Environ Health Perspect 1999;107:191-206.
154. Collins CH, Grange JM, Yates MD. Mycobacteria in water. J Appl Bacteriol 1984;57:193-211.
155. Falkinham JO. Epidemiology of infection by nontuberculous mycobacteria. Clin Microbiol Rev 1996;9:177-215.
156. Covert TC, Rodgers MR, Reyes AL, Stelma GN. Occurrence of nontuberculous mycobacteria in environmental samples. Appl Environ Microbiol 1999;65:2492-6.
157. von Reyn CF, Maslow JN, Barber TW, Falkinham JO, Arbeit RD. Persistent colonisation of potable water as a source of Mycobacterium avium infections in AIDS. Lancet 1994;343:1137-41.
158. Aronson T, Holtzman A, Glover N, et al. Comparison of large restriction fragments of Mycobacterium avium isolates recovered from AIDS and non-AIDS patients with those of isolates from potable water. J Clin Microbiol 1999;37:1008-12.
159. Mansfield KG, Lackner AA. Simian immunodeficiency virus-inoculated macaques acquire Mycobacterium avium from potable water during AIDS. J Infect Dis 1997;175:184-7.
160. Krishna Prasad BN, Gupta SK. Preliminary report on the engulfment and retention of mycobacteria by trophozoites of exenically grown Aanthamoeba castellanii Douglas, 1930. Curr Sci 1978;47:245-7.
161. Barker J, Brown MRW. Trojan horses of the microbial world: protozoa and the survival of bacterial pathogens in the environment. Microbiology 1994;140:1253-9.
162. Brown RC, Bass H, Coombs JP. Carbohydrate binding proteins involved in phagocytosis by Acanthamoeba. Nature 1975;254:434-5.
163. Allen PG, Dawidowicz EA. Phagocytosis in Acanthamoeba: I. A mannose receptor is responsible for the binding and phagocytosis of yeast. J Cell Physiol 1990;145:508-13.
164. Davies B, Chattings LS, Edwards SW. Superoxide generation during phagocytosis by Acanthamoeba castellanii similarities to the respiratory burst of immune phagocytes. J Gen Microbiol 1991;137:705-10.
165. Bozue JA, Johnson W. Interaction of Legionella pneumophilia with Acanthamoeba castellanii: uptake by coiling phagocytosis and inhibition of phagosome-lysosome fusion. Infect Immun 1996;64:668-73.
166. Brown MRW, Barker J. Unexplored reservoirs of pathogenic bacteria: protozoa and biofilms. Trends Microbiol 1999;7:46-50.
167. Cirillo JD. Exploring a novel perspective on pathogenic relationships. Trends Microbiol 1999;7:96-8.
168. Cirillo JD, Falkow S, Tompkins LS, Bermudez LE. Interaction of Mycobacterium avium with environmental amoebae enhances virulence. Infect Immun 1997;65:3759-67.
169. Steinert M, Birkness K, White E, Fields B, Quinn F. Mycobacterium avium bacilli grow saprozoically in coculture with Acanthamoeba polyphagia and survive within cyst walls. Appl Environ Microbiol 1998;64:2256-61.
170. Steinert M, Emody L, Amann R, Hacker J. Resuscitation of viable but nonculturable Legionella pneumophila Philadelphia JR32 by Acanthamoeba castellanii. Appl Environ Microbiol 1997;63:2047-53.
171. Ly TMC, Muller HE. Ingested Listeria monocytogenes survive and multiply in protozoa. J Med Microbiol 1990;33:51-4.
172. Barker J, Lambert PA, Brown MRW. Influence of intra-amoebic and other growth conditions on the surface of properties of Legionella pneumophila. Infect Immun 1993;61:3503-10.
173. Cirillo JD, Falkow S, Tompkins LS. Growth of Legionella pneumophila in Acanthamoeba castellanii enhances invasion. Infect Immun 1994;62:3254-61.
174. Barker J, Scaife H, Brown MRW. Intraphagocytic growth induces antibiotic-resistant phenotype of Legionella pneumophila. Antimicrob Agents Chemother 1995;39:2684-8.
175. King CH, Shotts EB, Wooley RE, Porter KG. Survival of coliforms and bacterial pathogens within protozoa during chlorination. Appl Environ Microbiol 1988;54:3023-3.
176. Kwaik YA, Gao L-Y, Harb OS, Stone BJ. Transcriptional regulation of the macrophage-induced gene (gspA) of Legionella pneumophilia and phenotypic characterization of a null mutant. Mol Microbiol 1997;24:629-42.
177. Fields BS. The molecular ecology of legionellae. Trends Microbiol 1996;4:286-90.
178. Kwaik YA, Gao L-Y, Stone BJ, Venkataraman C, Harb OS. Invasion of protozoa by Legionella pneumophilia and its role in bacterial ecology and pathogenesis. Appl Environ Microbiol 1998;64:3127-33.
179. Margulis L, Chapman MJ. Endosymbioses: cyclical and permanent in evolution. Trends Microbiol 1998;6:342-6.
180. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: A common cause of persistent infections. Science 1999;284:1318-22.
181. Potera C. Forging a link between biofilms and disease. Science 1999;283:1837-9.
182. Parker BC, Ford MA, Gruft H, Falkinham JO. Epidemiology of infection by nontuberculous mycobacteria. IV. Preferential aerosolisation of Mycobacterium intracellulare from natural waters. Am Rev Respir Dis 1983;128:652-6.
183. Blanchard DC, Syzdek L. Mechanism for the water-to-air transfer and concentration of bacteria. Science 1970;170:626-8.
184. Bonniere P, Wallaert B, Cortot A, et al. Latent pulmonary involvement in Crohn's disease: biological, functional, bronchoalveolar lavage and scintigraphic studies. Gut 1986;27:919-25.
185. Smiejan J-M, Cosnes J, Chollet-Martin S, et al. Sarcoid-like lymphocytosis of the lower respiratory tract in patients with active Crohn's disease. Ann Intern Med 1986;104:17-21.
186. Lemann M, Messing B, D'Agay F, Modigliani R. Crohn's disease with respiratory tract involvement. Gut 1987;28:1669-72.
187. Puntis JWL, Tarlow MJ, Raafat F, Booth IW. Crohn's disease of the lung. Arch Dis Child 1990;65:1270-1.
188. Louis E, Louis R, Shute J, et al. Bronchial eosinophilic infiltration in Crohn's disease in the absence of pulmonary disease. Clin Exp Allergy 1999;29:660-6.
189. Fireman Z, Osipov A, Yaffe H, et al. Assessment of pulmonary involvement in Crohn's disease by induced sputum. Gastroenterology 1999;116:A714. (Abst)
190. Mayberry J, Hitchens RAN. Distribution of Crohn's disease in Cardiff. Soc Sci Med 1978;12:137-8.
191. Hermon-Taylor J. Causation of Crohn's disease: The impact of clusters. Gastroenterology 1993;104:643-6.
192. Carson LA, Petersen NJ, Favero MS, Aguero SM. Growth characteristics of atypical mycobacteria in water and their comparative resistance to disinfectants. Appl Environ Microbiol 1978;36:839-46.
193. Taylor RH, Falkinham JO, Norton CD, LeChevallier MW. Chlorine, chloramine, chlorine dioxide and ozone susceptibility of Mycobacterium avium. Appl Environ Microbiol 2000;66:1702-5.
194. Schulze-Robbecke R, Janning B, Fischeder R. Occurrence of mycobacteria in biofilm samples. Tubercle Lung Dis 1992;73:141-4.
195. Rohr U, Weber S, Michel R, Selenka F, Wilhelm M. Comparison of free-living amoebae in hot water systems of hospitals with isolates from moist sanitary areas by identifying genera and determining temperature tolerance. Appl Environ Microbiol 1998;64:1822-4.
196. Gent AE, Hellier MD, Grace RH, Swarbrick ET, Coggon D. Inflammatory bowel disease and domestic hygiene in infancy. Lancet 1994;343:766-7.
197. Duggan AE, Usmani I, Neal KR, Logan RFA. Appendectomy, childhood hygiene, Helicobacter pylori status, and risk of inflammatory bowel disease: a case control study. Gut 1998;43:494-8.
198. Tamboli CP. A hypothesis for explaining the geographical distribution of Crohn's disease. Can J Gastroenterol 1996;10:173-7.
199. Bernstein CN, Blanchard JF, Rawsthorne P, Wajda A. Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: A population-based study. Am J Epidemiol 1999;149:916-24.
200. Loftus EV, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Crohn's disease in Olmsted County, Minnesota, 1940-1993: Incidence, prevalence and survival. Gastroenterology 1998;114:1161-8.
201. Bernstein CN, Blanchard JF. The epidemiology of Crohn's disease. Gastroenterology 1999;116:1503-6.
202. Chiodini RJ. Crohn's disease and the mycobacterioses: a review and comparison of two disease entities. Clin Microbiol 1989;2:90-117.
203. Chiodini RJ, Van Kruiningen HJ, Merkal RS, Thayer WR, Coutu JA. Characteristics of an unclassified Mycobacterium species isolated from patients with Crohn's disease. J Clin Microbiol 1984;20:966-71.
204. Coloe P, Wilkes CR, Lightfoot D, Tosolini FA. Isolation of Mycobacterium paratuberculosis in Crohn's disease. Aust Microbiol 1986;7:188A. (Abst)
205. Gitnick G, Collins J, Beaman B, et al. Preliminary report on isolation of mycobacteria from patients with Crohn's disease. Dig Dis Sci 1989;34:925-32.
206. Thorel M-F. Relationship between Mycobacterium avium, M. paratuberculosis and mycobacteria associated with Crohn's disease. Ann Rech Vet 1989;20:417-29.
207. Haagsma J, Mulder CJJ, Eger A, Tytgat GNJ. Mycobacterium paratuberculosis isole chez des patients atteints de maladie de Crohn. Resultats preliminaires. Acta Endosc 1991;21:255-60.
208. Pavlik I, Bejckova L, Koskova S, Fixa B, Komarkova O, Bedrna J. DNA fingerprinting as a tool for epidemiological studies of paratuberculosis in ruminants and Crohn's disease. In: Chiodini RJ, Collins MR, Bassey E, eds. Proceedings of the Fourth International Colloquium on Paratuberculosis. Rehoboth: International Association for Paratuberculosis Inc, 1994:279-89.
209. Moss MT, Sanderson J, Tizard M, et al. PCR detection of Mycobacterium paratuberculosis in long term cultures from Crohn's disease tissues. Gut 1992;33:1209-13.
210. Wall S, Kunze ZM, Saboor S, et al. Identification of spheroplast-like agents isolated from tissues of patients with Crohn's disease and control tissues by polymerase chain reaction. J Clin Microbiol 1993;31:1241-5.
211. Sanderson JD, Moss MT, Tizard MLV, Hermon-Taylor J. Mycobacterium paratuberculosis DNA in Crohn's disease tissue. Gut 1992;33:890-6.
212. Lisby G, Andersen J, Engbaek K, Binder V. Mycobacterium paratuberculosis in intestinal tissue from patients with Crohn's disease demonstrated by a nested primer polymerase chain reaction. Scand J Gastroenterol 1994;29:923-9.
213. Dell'Isola B, Poyart C, Goulet O, et al. Detection of Mycobacterium paratuberculosis by polymerase chain reaction in children with Crohn's disease. J Infect Dis 1994;169:449-51.
214. Fidler HM, Thurrell W, Johnson NM, Rook GAW, McFadden JJ. Specific detection of Mycobacterium paratuberculosis DNA associated with granulomatous tissue in Crohn's disease. Gut 1994;35:506-10.
215. Murray A, Oliaro J, Schlup MMT, Chadwick VS. Mycobacterium paratuberculosis and inflammatory bowel disease: frequency distribution in serial colonoscopic biopsies using the polymerase chain reaction. Microbiology 1995;83:217-28.
216. Suenaga K, Yokoyama Y, Okazaki K, Yamamoto Y. Mycobacteria in the intestine of Japanese patients with inflammatory bowel disease. Am J Gastroenterol 1995;90:76-80.
217. Erasmus DL, Victor TC, Van Eeden PJ, Falck V, Van Helden P. Mycobacterium paratuberculosis and Crohn's disease. Gut 1995;36:942.
218. Gan H, Ouyang Q, Bu H. Mycobacterium paratuberculosis in the intestine of patients with Crohn's disease. Chung Hua Nei Ko Tsa Chih 1997;36:228-30.
219. Del Prete R, Quaranta M, Lippolis A, et al. Detection of Mycobacterium paratuberculosis in stool samples of patients with inflammatory bowel disease by IS900-based PCR and colorimetric detection of amplified DNA. J Microbiol Methods 1998;33:105-114.
220. Rowbotham DS, Mapstone NP, Trejdosiewicz LK, Howdle PD, Quirke P. Mycobacterium paratuberculosis DNA not detected in Crohn's disease tissue by fluorescent polymerase chain reaction. Gut 1995;37:660-7.
221. Dumonceau J-M, Van Gossum A, Adler M, et al. No Mycobacterium paratuberculosis found in Crohn's disease using the polymerase chain reaction. Dig Dis Sci 1996;41:421-6.
222. Frank TS, Cook SM. Analysis of paraffin sections of Crohn's disease for Mycobacterium paratuberculosis using polymerase chain reaction. Modern Pathol 1996;9:32-5.
223. Al-Shamali M, Khan I, Al-Nakib B, Al-Hassan F, Mustafa AS. A multiplex polymerase chain reaction assay for the detection of Mycobacterium paratuberculosis DNA in Crohn's disease tissue. Scand J Gastroenterol 1997;32:819-23.
224. Kallinowski F, Wassmer A, Hofmann MA, et al. Prevalence of enteropathogenic bacteria in surgically treated chronic inflammatory bowel disease. Hepatogastroenterol 1998;45:1552-8.
225. Clarkson WK, Presti ME, Petersen PF, et al. Role of Mycobacterium paratuberculosis in Crohn's disease. Dis Colon Rectum 1998;41:195-9.
226. Chiba M, Fukushima T, Horie Y, Iizuka M, Masamune O. No Mycobacterium paratuberculosis detected in intestinal tissue, including Peyer's patches and lymph follicles, of Crohn's disease. J Gastroenterol 1998;33:482-7.
227. Cellier C, De Beenhouwer H, Berger A, et al. Mycobacterium paratuberculosis and Mycobacterium avium subsp silvaticum DNA cannot be detected by PCR in Crohn's disease tissue. Gastroenterol Clin Biol 1998;22:675-8.
228. Kanazawa K, Haga Y, Funakoshi O, Nakajima H, Munakata A, Yoshida Y. Absence of Mycobacterium paratuberculosis DNA in intestinal tissues from Crohn's disease by nested polymerase chain reaction. J Gastroenterol 1999;34:200-6.
229. Tiveljung A, Soderholm JD, Olaison G, Jonasson J, Monstein H-J. Presence of eubacteria in biopsies from Crohn's disease inflammatory lesions as determined by 16S rRNA gene-based PCR. J Med Microbiol 1999;48:263-8.
230. Noordhoek GT, Kolk AHJ, Bjune G, et al. Sensitivity and specificity of PCR for detection of Mycobacterium tuberculosis: a blind comparison study among seven laboratories. J Clin Microbiol 1994;32:277-84.
231. Schmidt BL. PCR in laboratory diagnosis of human Borrelia burgdorferi infections. Clin Microbiol Rev 1997;10:185-201.
232. Navarro E, Fernandez JA, Escribano J, Solera J. PCR assay for diagnosis of human brucellosis. J Clin Microbiol 1999;37:1654-5.
233. de Wit MYL, Faber WR, Kreig SR, et al. Application of a polymerase chain reaction for the detection of Mycobacterium leprae in skin tissue. J Clin Microbiol 1991;29:906-10.
234. Hermon-Taylor J. The causation of Crohn's disease and treatment with antimicrobial drugs. Ital J Gastroenterol Hepatol 1998;30:607-10.
235. Hermon-Taylor J, Barnes N, Clarke C, Finlayson C. Mycobacterium paratuberculosis cervical lymphadenitis, followed five years later by terminal ileitis similar to Crohn's disease. Br Med J 1998;316:449-53.
236. Schwartz D, Shafran I, Romero C, et al. Use of short-term culture for identification of Mycobacterium avium subsp paratuberculosis in tissue from Crohn's disease patients. Clin Microbiol Infect. (In press)
237. Naser S, Schwartz D, Shafran I. Isolation of Mycobacterium avium subsp paratuberculosis from breast milk of Crohn's disease patients. Am J Gastroenterol 2000;95:1094-5.
238. Schmidt BL, Aberer E, Stockenhuber C, Klade H, Breier F, Luger A. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in the urine and breast milk of patients with lyme borreliosis. Diagn Microbiol Infect Dis 1995;21:121-8.
239. Matthews N, Mayberry JF, Rhodes J, et al. Agglutinins to bacteria in Crohn's disease. Gut 1980;21:376-80.
240. Thayer WR, Coutu JA, Chiodini RJ, Van Kruiningen HJ, Merkal RS. Possible role of mycobacteria in inflammatory bowel disease. Dig Dis Sci 1984;29:1080-5.
241. Cho S-N, Brennan PJ, Yoshimura HH, Korelitz BI, Graham DY. Mycobacterial aetiology of Crohn's disease: serologic study using common mycobacterial antigens and a species-specific glycolipid antigen from Mycobacterium paratuberculosis. Gut 1986;27:1353-6.
242. Brunello F, Pera A, Martini S, et al. Antibodies to Mycobacterium paratuberculosis in patients with Crohn's disease. Dig Dis Sci 1991;36:1741-5.
243. Tanaka K, Wilks M, Coates PJ, Farthing MJG, Walker-Smith JA, Tabaqchali S. Mycobacterium paratuberculosis and Crohn's disease. Gut 1991;32:43-5.
244. Morgante P, Lopez B, Barrera L, Ritacco V, de Kantor IN. Respuesta humoral a micobacterias en pacientes con enfermedad de Crohn. Medicina (Buenos Aires) 1994;54:97-102.
245. Chiodini RJ. Abolish Mycobacterium paratuberculosis strain 18. J Clin Microbiol 1993;31:1956-7.
246. Kobayashi K, Brown WR, Brennan PJ, Blaser MJ. Serum antibodies to mycobacterial antigens in active Crohn's disease. Gastroenterology 1988;94:1404-11.
247. Markesich DC, Sawai ET, Butel JS, Graham DY. Investigations on etiology of Crohn's disease. Humoral response to stress (heat shock) proteins. Dig Dis Sci 1991;36:454-60.
248. Stainsby KJ, Lowes JR, Allan RN, Ibbotson JP. Antibodies to Mycobacterium paratuberculosis and nine species of environmental mycobacteria in Crohn's disease and control subjects. Gut 1993;34:371-4.
249. Suenaga K, Yokoyama Y, Nishimori I, et al. Serum antibodies to Mycobacterium paratuberculosis in patients with Crohn's disease. Dig Dis Sci 1999;44:1202-7.
250. Seldenrijk CA, Drexhage HA, Meuwissen SGM, Meijer CJLM. T-cellular immune reactions (in macrophage inhibition factor assay) against Mycobacterium paratuberculosis, Mycobacterium kansasii, Mycobacterium tuberculosis, Mycobacterium avium in patients with chronic inflammatory bowel disease. Gut 1990;31:529-35.
251. Ibbotson JP, Lowes JR, Chahal H, et al. Mucosal cell-mediated immunity to mycobacterial, enterobacterial and other microbial antigens in inflammatory bowel disease. Clin Exp Immunol 1992;87:224-30.
252. Rowbothem DS, Howdle PD, Trejdosiewicz LK. Peripheral cell-mediated immune response to mycobacterial antigens in inflammatory bowel disease. Clin Exp Immunol 1995;102:456-61
253. Chiodini RJ, Thayer WR, Coutu JA. Presence of Mycobacterium paratuberculosis in animal health care workers. In: Chiodini RJ, Hines ME, Collins MT eds. Proceedings of the Fifth International Colloquium on Paratuberculosis. Rehoboth: International Association for Paratuberculosis Inc, 1996:324-8.
254. Elsaghier A, Prantera C, Moreno C, Ivanyi J. Antibodies to Mycobacterium paratuberculosis-specific protein antigens in Crohn's disease. Clin Exp Immunol 1992;90:503-8.
255. Gilot P, de Kesel M, Machtelinckx L, Coene M, Cocito C. Isolation and sequencing of the gene coding for an antigenic 34-kilodalton protein of Mycobacterium paratuberculosis. J Bacteriol 1993;175:4930-5.
256. Vannuffel P, Dieterich C, Naerhuyzen B, et al. Occurrence, in Crohn's disease, of antibodies directed against a species-specific recombinant polypeptide of Mycobacterium paratuberculosis. Clin Diagn Lab Immunol 1994;1:241-3.
257. El-Zaatari FAK, Naser SA, Engstrand L, Hachem CY, Graham DY. Identification and characterization of Mycobacterium paratuberculosis recombinant proteins expressed in E.coli. Curr Microbiol 1994;29:177-84.
258. El-Zaatari FAK, Naser SA, Graham DY. Characterization of specific Mycobacterium paratuberculosis recombinant clone expressing 35,000-molecular weight antigen and reactivity with sera from animals with clinical and subclinical Johne's disease. J Clin Microbiol 1997;35:1794-9.
259. El-Zaatari FAK, Naser SA, Hulten K, Burch P, Graham DY. Characterization of Mycobacterium paratuberculosis p36 antigen and its seroreactivities in Crohn's disease. Curr Microbiol 1999;39:115-9.
260. Naser S, Shafran El-Zaatari FAK. Mycobacterium avium subsp. paratuberculosis in Crohn's disease is serologically positive. Clin Diagn Lab Immunol 1999;6:282.
261. Sumar N, Tizard MLV, Doran T, Austen BM, Hermon-Taylor J. Epitope mapping of IS900 +ve strand encoded protein p43 using sera from humans with chronic enteritis Crohn's disease. In: Chiodini RJ, Collins MT, Bassey EO, eds. Proceedings of the Fourth International Colloquium on Paratuberculosis. Rehoboth: International Association for Paratuberculosis Inc, 1994:273-8.
262. Reddy M, Sumar N, Martin H, Bull T, Tizard MLV, Hermon-Taylor J. A peptide epitope in the C-terminus of p43 encoded by IS900 in Mycobacterium paratuberculosis is recognised by Crohn's disease sera. Digestion 1998;59(Suppl 3):114.
263. Wurzner R. Evasion of pathogens by avoiding recognition or eradication by complement, in part via molecular mimicry. Mol Immunol 1999;36:249-60.
264. Schorey JS, Carroll MC, Brown EJ. A macrophage invasion mechanism of pathogenic mycobacteria. Science 1997;277:1091-3.
265. Britton WJ, Roche PW, Winter N. Mechanisms of persistence of mycobacteria. Trends Microbiol 1994;2:284-8
266. Parrish NM, Dick JD, Bishai WR. Mechanisms of latency in Mycobacterium tuberculosis. Trends Microbiol 1998;6:107-12.
267. Maddox J. Psychoimmunology before its time. Nature 1984;309:400.
268. Drossman DA. Gastrointestinal illness and the biopsychosocial model. Psychosomat Med 1998;60:258-67.
269. Vanham G, Toossi Z, Hirsch CS, et al. Examining a paradox in the pathogenesis of human pulmonary tuberculosis: immune activation and suppression/anergy. Tuberc Lung Dis 1997;78:145-58.
270. Godfrey HP. Pathogenesis of chronic bacterial infections. Trends Microbiol 1998;6:303.
271. Peeters M, Geypens B, Claus D, et al. Clustering of increased small intestinal permeability in families with Crohn's disease. Gastroenterology 1997;113:802-7.
272. Soderholm JD, Olaison G, Lindberg E, et al. Different intestinal permeability patterns in relatives and spouses of patients with Crohn's disease: an inhereted defect in mucosal defence? Gut 1999;44:96-100.
273. Soderholm JD, Peterson KH, Olaison G, et al. Epithelial permeability to proteins in the noninflamed ileum of Crohn's disease? Gastroenterology 1999;117:65-72.
274. Baldassano RN, Schreiber S, Johnston RB, Fu RD, Muraki T, MacDermott RP. Crohn's disease monocytes are primed for accentuated release of toxic oxygen metabolites. Gastroenterology 1993;105:60-6.
275. Tsuyuguchi I, Kawasumi H, Takashima T, Tsuyuguchi T, Kishimoto S. Mycobacterium avium-Mycobacterium intracellulare complex-induced suppression of T-cell proliferation in vitro by regulation of monocyte accessory cell activity. Infect Immun 1990;58:1369-78.
276. Holland SM. Host defense against nontuberculous mycobacterial infections. Semin Respir Infect 1996;11:217-30.
277. Moura AC, Mariano M. Lipids from Mycobacterium leprae cell wall suppress T-cell activation in vivo and in vitro. Immunology 1997;92:429-36.
278. VanHeyningen TK, Collins HL, Russel DG. IL-6 produced by macrophages infected with mycobacterium species suppresses T cell responses. J Immunol 1997;158:330-7.
279. Murray PJ, Wang L, Onufryk C, Tepper RI, Young RA. T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. J Immunol 1997;158:315-21.
280. Chatterjee D, Khoo KH. Mycobacterial lipoarabinomannan: an extraordinary lipoheteroglycan with profound physiological effects. Glycobiology 1998;8:113-20.
281. Stenger S, Niazi KR, Modlin RL. Down-regulation of CD1 on antigen-presenting cells by infection with Mycobacterium tuberculosis. J Immunol 1998;161:3582-8.
282. George KM, Chatterjee D, Gunawardana G, et al. Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence. Science 1999;283:854-7.
283. Schreiber S, Heinig T, Panzer U, et al. Impaired response of activated mononuclear phagocytes to interleukin 4 in inflammatory bowel disease. Gastroenterology 1995;108:21-3.
284. West GA, Matsuura T, Levine AD, Klein JS, Fiocchi C. Interleukin 4 in inflammatory bowel disease and mucosal immune reactivity. Gastroenterology 1996;110:1683-95.
285. Leach MW, Davidson NJ, Fort MM, Powrie F, Rennick DM. The role of IL-10 in inflammatory bowel disease: "of mice and men". Toxicol Pathol 1999;27:123-33.
286. Monteleone G, Trapasso F, Parrello T, et al. Bioactive IL-18 expression is up-regulated in Crohn's disease. J Immunol 1999;163:143-7.
287. Sellon RK, Tonkonogy S, Schultz M, et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 1998;66:5224-31.
288. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993;75:263-74.
289. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993;75:253-61.
290. Hermiston ML, Gordon JI. Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science 1995;270:1203-7.
291. Geboes K, Rutgeerts P, Ectors N, et al. Major histocompatibility class II expression on the small intestinal nervous system in Crohn's disease. Gastroenterology 1992;103:439-47.
292. D'Haens G, Colpaert S, Peeters M, et al. The presence and severity of neural inflammation predict severe postoperative recurrence of Crohn's disease. Gastroenterology 1998;114:A963. (Abst)
293. Rambukkana A, Yamada H, Zanazzi G, et al. Role of alpha-dystroglycan as a Schwann cell receptor for Mycobacterium leprae. Science 1998;282:2076-9.
294. Weinstein DE, Freedman VH, Kaplan G. Molecular mechanism of nerve infection in leprosy. Trends Microbiol 1999;7:185-6.
295. Larsen AB, Vardaman TH, Groth AH. Preliminary studies on the effect of streptomycin and other agents on Mycobacterium paratuberculosis. Am J Vet Res 1950;11:374-7.
296. Larsen AB, Vardaman TH. The effect of isonicotinic acid hydrazide on Mycobacterium paratuberculosis. J Am Vet Med Assoc 1953;122:309-10.
297. Rankin JD. Isoniazid: its effect on Mycobacterium Johnei in vitro and its failure to cure clinical Johne's disease in cattle. Vet Rec 1953;65:640-51.
298. Rankin JD. An attempt to prevent the establishment of Mycobacterium johnei in calves by means of isoniazid alone and in combination with streptomycin. Vet Rec 1955;67:1105-7.
299. Gilmour NJL. The failure of the rimino phenazine B663 (G30320) to reduce the level of experimental Mycobacterium johnei infection in calves. Br Vet J 1970;126:5-6.
300. Gilmour NJL, Angus KW. Effect of the rimino phenazine B663 (G30320) on Mycobacterium johnei infection and reinfection in sheep. J Comp Path 1971;81:221-6.
301. Merkal RS, Larsen AB. Clofazimine treatment of cows naturally infected with Mycobacterium paratuberculosis. Am J Vet Res 1973;34:27-8.
302. Baldwin EW. Isoniazid therapy in two cases of Johne's disease. Vet Med Small Anim Clin 1976;71:1359-62.
303. Slocombe RF. Combined streptomycin-isoniazid-rifampin therapy in the treatment of Johne's disease in a goat. Can Vet J 1982;23:160-3.
304. Gezon HM, Bither HD, Gibbs HC, et al. Identification and control of paratuberculosis in a large goat herd. Am J Vet Res 1988;49:1817-23.
305. Hoffsis GF, Streeter RN, Rings DM, St Jean G. Therapy for Johne's disease. Bovine Pract 1990;25:55-8.
306. Belloli A, Arrigoni N, Belletti GL, Proverbio D, Greppi G, Vacirca G. First results of paratuberculosis therapy in calves intravenously infected with Mycobacterium paratuberculosis. In: Chiodini RJ, Kreeger JM, eds. Proceedings of the Third International Colloquium on Paratuberculosis. Rehoboth: International Association for Paratuberculosis Inc, 1991:144-6.
307. Das SK, Sinha RP, Chauhan HVS. Chemotherapy of paratuberculosis in goats: streptomycin, rifampicin and levamisole versus streptomycin, rifampicin and dapsone. Ind J Anim Sci 1992;62:8-13.
308. Mondal D, Sinha RP, Gupta MK. Effect of combination therapy in Mycobacterium paratuberculosis infected rabbits. Ind J Exp Biol 1994;32:318-23.
309. St Jean G. Treatment of clinical paratuberculosis in cattle. Vet Clin North Am Food Anim Pract 1996;12:417-30.
310. Ward M, McManus JPA. Dapsone in Crohn's disease. Lancet 1975;i:1236-7.
311. Paris JC, Simon V, Paris J. Etude critique des effets de la medication antituberculeuse dans une serie e 52 cas de formes severes de la maladie de Crohn. Ann Gastroenterol Hepatol 1977;13:427-33.
312. Toulet J, Rousselet J, Viteau J-M. La rifampicine dans le traitement de la maladie de Crohn. Gastroenterol Clin Biol 1979;3:209-11.
313. Schultz MG, Rieder HL, Hersh T, Riepe S. Remission of Crohn's disease with antimycobacterial chemotherapy. Lancet 1987;ii:1391.
314. Warren JB, Rees HC, Cox TM. Remission of Crohn's disease with tuberculosis chemotherapy. N Engl J Med 1986;314:182.
315. Wirostko E, Johnson L, Wirostko B. Crohn's disease: Rifampin treatment of the ocular and gut disease. Hepatogastroenterology 1987;34:90-3.
316. Picciotto A, Gesu GP, Schito GC, Testa R, Varagona G, Celle G. Antimycobacterial chemotherapy in two cases of inflammatory bowel disease. Lancet 1988;i:536-7.
317. Prantera C, Bothamley G, Levenstein S, Mangiarotti R, Argentieri R, Crohn's disease and mycobacteria: two cases of Crohn's disease with high anti-mycobacterial antibody levels cured by dapsone therapy. Biomed Pharmacother 1989;43:295-9.
318. Hampson SJ, Parker MC, Saverymuttu SH, Joseph AE, McFadden J-JP, Hermon-Taylor J. Quadruple antimycobacterial chemotherapy in Crohn's disease: results at 9 months of a pilot study in 20 patients. Aliment Pharmacol Ther 1989;3:343-52.
319. Janerot G, Rolny P, Wickbom G, Alemayehu G. Antimycobacterial therapy ineffective in Crohn's disease after a year. Lancet 1989;i:164-5.
320. Shaffer JL, Hughes S, Linaker BD, Baker RD, Turnberg LA. Controlled trial of rifampicin and ethambutol in Crohn's disease. Gut 1984;25:203-5.
321. Afdhal NH, Long A, Lennon J, Crowe J, O'Donoghue DP. Controlled trial of antimycobacterial therapy in Crohn's disease. Dig Dis Sci 1991;36:449-53.
322. Rutgeerts P, Geboes K, Vantrappen G, et al. Rifabutin and ethambutol do not help recurrent Crohn's disease in the neoterminal ileum. J Clin Gastroenterol 1992;15:24-8.
323. Prantera C, Kohn A, Mangiarotti R, Andreoli A, Luzi C. Antimycobacterial therapy in Crohn's disease: results of a controlled, double-blind trial with a multiple antibiotic regimen. Am J Gastroenterol 1994;89:513-8.
324. Swift GL, Srivastava ED, Stone R, et al. Controlled trial of antituberculous chemotherapy for two years in Crohn's disease. Gut 1994;35:363-8.
325. Thomas GAO, Swift GL, Green JT, et al. Controlled trial of antituberculous chemotherapy in Crohn's disease: a five year follow up study. Gut 1998;42:497-500.
326. Wolinsky E. Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis 1979;119:107-59.
327. Iseman MD, Corpe RF, O'Brien RJ, Rosenzwieg DY, Wolinsky E. Disease due to Mycobacterium avium-intracellulare. Chest 1985;87(2Suppl):139S-49S.
328. Korvick JA, Benson CA, eds. Mycobacterium avium-Complex Infection. Lung Biology in Health and Disease, vol 87. New York: Marcel Dekker, 1996.
329. Barry CE, Mdluli K. Drug sensitivity and environmental adaptation of mycobacterial cell wall components. Trends Microbiol 1996;4:275-81.
330. Bottger EC. Resistance to drugs targeting protein synthesis in mycobacteria. Trends Microbiol 1994;2:416-21.
331. Rastogi N, Falkinham JO. Solving the dilemma of antimycobacterial chemotherapy. Res Microbiol 1996;147:7-10
332. Lety MA, Nair S, Berche P, et al. A single point mutation in the embB gene is responsible for resistance to ethambutol in Mycobacterium smegmatis. Antimicrob Agents Chemother 1997;41:2629-33.
333. Musser JM. Antimicrobial agent resistance in Mycobacteria: molecular genetic insights. Clin Microbiol Rev 1995;8:496-514.
334. O'Brien RJ, Lyle MA, Snider DE. Rifabutin(ansamycin LM 427): A new rifamycin-S derivative for the treatment of mycobacterial diseases. Rev Infect Dis 1987;9:519-30.
335. Brogden RN, Fitton A. Rifabutin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1994;47:983-1009.
336. Saito J, Sato K, Tomioka H. Comparative in vitro and in vivo activity of rifabutin and rifampicin against Mycobacterium avium complex. Tubercle 1988;69:187-92.
337. Inderlied CB, Kolonoski PT, Wu M, Young LS. In vitro and in vivo activity of azithromycin (CP 62,993) against the Mycobacterium avium complex. J Infect Dis 1989;159:994-7.
338. Rastogi N, Labrousse V. Extracellular and intracellular activities of clarithromycin used alone and in association with ethambutol and rifampin against Mycobacterium avium complex. Antimicrob Agents Chemother 1991;35:462-70.
339. Piersimoni C, Tortoli E, Mascellino MT, et al. Activity of seven antimicrobial agents, alone and in combination, against AIDS-associated isolates of Mycobacterium avium complex. J Antimicrob Chemother 1995;36:497-502.
340. Onyeji CO, Nightingale CH, Tessier PR, Nicolau DP, Bow LM. Activities of clarithromycin, azithromycin and ofloxacin in combination with liposomal or unencapsulated granulocyte-macrophage colony-stimulating factor against intramacrophage Mycobacterium avium-Mycobacterium intracellulare. J Infect Dis 1995;172:810-6.
341. Gladue RP, Snider ME. Intracellular accumulation of azithromycin by cultured human fibroblasts. Antimicrob Agents Chemother 1990;34:1056-60.
342. Chiodini RJ. Antimicrobial activity of rifabutin in combination with two and three other antimicrobial agents against strains of Mycobacterium paratuberculosis. J Antimicrob Chemother 1991;27:171-6.
343. Rastogi N, Goh KS, Labrousse V. Activity of clarithromycin compared with those of other drugs against Mycobacterium paratuberculosis and further enhancement of its extracellular and intracellular activities by ethambutol. Antimicrob Agents Chemother 1992;36:2843-6.
344. Ghebremichael S, Svenson SB, Kallenius G, Hoffner SE. Antimycobacterial synergism of clarithromycin and rifabutin. Scand J Infect Dis 1996;28:387-90.
345. Thayer W, Coutu J, Chiodini R, et al. Use of rifabutin and streptomycin in the therapy of Crohn's disease - preliminary results. In: MacDermott RP, ed. Inflammatory Bowel Disease. Current Status and Future Approach. Amsterdam: Elsevier, 1988:565-8.
346. Graham DY, Al-Assi MT, Robinson M. Prolonged remission in Crohn's disease following therapy for Mycobacterium paratuberculosis infection. Gastroenterology 1995;108:A826. (Abst)
347. Goodgame RW, Kimball K, Akram S, Graham DY, Ou C-N. Randomized controlled trial of clarithromycin & ethambutol in the treatment of Crohn's disease. Gasteroenterology 1999;116:A725. (Abst)
348. Leiper K, Campbell BJ, Rhodes JM. Treatment of active Crohn's disease with clarithromycin. Gut 1999;44:299.
349. Meier A, Heifets L, Wallace RJ, et al. Molecular mechanisms of clarithromycin resistance in Mycobacterium avium: observation of multiple 23S rDNA mutations in a clonal population. J Infect Dis 1996;174:354-60.
350. Ji B, Lounis N, Truffot-Pernot C, Grosset J. Selection of resistant mutants of Mycobacterium avium in beige mice by clarithromycin monotherapy. Antimicrob Agents Chemother 1992;36:2839-40.
351. Doucet-Populaire F, Truffot-Pernot C, Grosset J, Jarlier V. Acquired resistance in Mycobacterium avium complex strains isolated from AIDS patients and beige mice during treatment with clarithromycin. J Antimicrob Chemother 1995;36:129-36.
352. Bermudez LE, Petrofsky M, Kolonoski P, Young LS. Emergence of Mycobacterium avium populations resistant to macrolides during experimental chemotherapy. Antimicrob Agents Chemother 1998;42:180-3.
353. Gui GPH, Thomas PRS, Tizard MLV, Lake J, Sanderson JD, Hermon-Taylor J. Two-year-outcomes analysis of Crohn's disease treated with rifabutin and macrolide antibiotics. J Antimicrob Chemother 1997;39:393-400.
354. Borody TJ, Pearce L, Bampton PA, et al. Treatment of severe Crohn's disease (CD) using rifabutin-macrolide-clofazimine combination: interim report. Gastroenterology 1998;114:A938. (Abst)
355. Palumbo M, Gatto B, Zagotto G, Palu G. On the mechanism of action of quinolone drugs. Trends Microbiol 1993;1:232-5.
356. Dong Y, Xu C, Shao X, Domagala J, Drlica K. Fluoroquinolone action against mycobacteria: Effects of C-8 substituents on growth, survival, and resistance. Antimicrob Agents Chemother 1998;42:2978-84.
357. Sirgel FA, Venter A, Heilmann H-D. Comparative in-vitro of Bay y3118. a new quinolone, and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex. J Antimicrob Chemother 1995;35:349-51.
358. Sigurdsson B. A killed vaccine against paratuberculosis (Johne's disease) in sheep. Am J Vet Res 1960;21:54.
359. Stuart P. Vaccination against Johne's disease in cattle exposed to experimental infection. Br Vet J 1965;121:289-318.
360. Wilesmith JW. Johne's disease: a retrospective study of vaccinated herds in Great Britain. Br Vet J 1982;138:321-31.
361. Saxegaard F, Fodstad FH. Control of paratuberculosis (Johne's disease) in goats by vaccination. Vet Rec 1985;116:439.
362. Juste RA, Casal J. An economic and epidemiologic simulation of different control strategies for ovine paratuberculosis. Prev Vet Med 1993;15:101.
363. Cranwell MP. Control of Johne's disease in a flock of sheep by vaccination. Vet Rec 1993;133:219.
364. Kormendy B. The effect of vaccination on the prevalence of paratuberculosis in large dairy herds. Vet Microbiol 1994;41:117-25.
365. Perez V, Garcia Marin JF, Bru R, Moreno B, Badiola JJ. Results of vaccination of adult animals against ovine paratuberculosis. Med Vet 1995;12:196-201.
366. van Shaik G, Kalis CHJ, Benedictus G, Dijkhuizen AA, Huirne RBM. Cost-benefit analysis of vaccination against paratuberculosis in dairy cattle. Vet Rec 1996;139:624-7.
367. Lowrie DB, Tascon RE, Bonato VLD, et al. Therapy of tuberculosis in mice by DNA vaccination. Nature 1999;400:269-71.
368. Velaz-Faircloth M, Cobb AJ, Horstman AL, Henry SC, Frothingham R. Protection against Mycobacterium avium by DNA vaccines expressing mycobacterial antigens as fusion proteins with green fluorescent protein. Infect Immun 1999;67:4243-50.
369. Harris NB, Feng Z, Liu X, Cirillo SLG, Cirillo JD, Barletta RG. Development of a transposon mutagenesis system for Mycobacterium avium subsp. paratuberculosis. FEMS Microbiol 1999;175:21-6.